Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry

Terminated

• Conditions: Myeloproliferative Disorders (MPD); Myeloproliferative Disorders

• Registration Number: NCT01144780
• Lead Sponsor: Stanford University

Brief Summary

The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09
• Study First Submitted: 2010-06-14
• Study First Submitted QC: 2010-06-15
• Study First Posted: 2010-06-16
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-07
• Last Update Posted: 2020-04-09

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).

Read More

Exclusion Criteria

Any patient who is not willing to give consent.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States